Free Trial

Cronos Group (NASDAQ:CRON) Sets New 12-Month Low - Should You Sell?

Cronos Group logo with Medical background

Cronos Group Inc. (NASDAQ:CRON - Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $1.61 and last traded at $1.62, with a volume of 221919 shares trading hands. The stock had previously closed at $1.71.

Cronos Group Stock Up 4.2 %

The company has a market cap of $669.43 million, a price-to-earnings ratio of -13.46, a PEG ratio of 1.74 and a beta of 1.02. The business has a 50-day simple moving average of $1.88 and a two-hundred day simple moving average of $1.99.

Institutional Investors Weigh In On Cronos Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in CRON. Formidable Asset Management LLC lifted its stake in shares of Cronos Group by 2.1% in the fourth quarter. Formidable Asset Management LLC now owns 278,398 shares of the company's stock worth $562,000 after buying an additional 5,637 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in Cronos Group by 64.5% in the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after acquiring an additional 6,520 shares during the period. Tower Research Capital LLC TRC lifted its position in Cronos Group by 140.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after acquiring an additional 8,019 shares during the last quarter. Kerrisdale Advisers LLC grew its position in shares of Cronos Group by 2.3% in the fourth quarter. Kerrisdale Advisers LLC now owns 468,786 shares of the company's stock valued at $947,000 after purchasing an additional 10,539 shares during the last quarter. Finally, Thompson Davis & CO. Inc. bought a new position in shares of Cronos Group in the fourth quarter worth about $29,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

About Cronos Group

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Featured Articles

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines